nodes	percent_of_prediction	percent_of_DWPC	metapath
Homatropine Methylbromide—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00561	0.0058	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00537	0.00555	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00527	0.00545	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00527	0.00545	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00515	0.00533	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00514	0.00531	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00509	0.00526	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00505	0.00522	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00505	0.00522	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.00504	0.00522	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00472	0.00488	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.00469	0.00485	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00466	0.00482	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00464	0.0048	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.00464	0.0048	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.0046	0.00476	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.00454	0.0047	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00452	0.00468	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.00441	0.00456	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.00441	0.00456	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00441	0.00456	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.0044	0.00455	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00436	0.00451	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00436	0.0045	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00435	0.0045	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00431	0.00446	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00427	0.00442	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00422	0.00436	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00418	0.00432	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00417	0.00431	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00415	0.00429	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00414	0.00428	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00413	0.00427	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.0041	0.00424	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00409	0.00423	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00404	0.00418	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00401	0.00415	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00401	0.00415	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00401	0.00415	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00392	0.00406	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00384	0.00398	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00384	0.00398	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00384	0.00397	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00382	0.00395	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00378	0.00391	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00377	0.0039	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00376	0.00388	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—skin of body—acquired immunodeficiency syndrome	0.00374	0.113	CbGeAlD
Homatropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00373	0.00386	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00366	0.00379	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00361	0.00374	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00355	0.00368	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00355	0.00368	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00355	0.00367	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00354	0.00366	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00354	0.00366	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00351	0.00363	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00351	0.00363	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00346	0.00358	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.0034	0.00351	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.00336	0.00347	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00318	0.00329	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00317	0.00328	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00314	0.00325	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00305	0.00316	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.00302	0.00313	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—nervous system—acquired immunodeficiency syndrome	0.00296	0.0893	CbGeAlD
Homatropine Methylbromide—CHRM5—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00292	0.00302	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00288	0.00298	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00287	0.00297	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—central nervous system—acquired immunodeficiency syndrome	0.00285	0.086	CbGeAlD
Homatropine Methylbromide—CHRM1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00284	0.00294	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00284	0.00294	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00283	0.00293	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00281	0.0029	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00275	0.00285	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—TAT—acquired immunodeficiency syndrome	0.00274	0.00283	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00271	0.0028	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00271	0.0028	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.0027	0.0028	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.0027	0.00279	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.0027	0.00279	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.0027	0.00279	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00267	0.00276	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00267	0.00276	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00267	0.00276	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00264	0.00273	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00264	0.00273	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00263	0.00272	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00261	0.0027	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00258	0.00267	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00257	0.00266	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00254	0.00263	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00244	0.00252	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00243	0.00251	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00242	0.00251	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00241	0.0025	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.0024	0.00249	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00239	0.00247	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00238	0.00247	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00236	0.00244	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00233	0.00241	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00232	0.0024	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00232	0.0024	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00232	0.0024	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—nervous system—acquired immunodeficiency syndrome	0.00231	0.0698	CbGeAlD
Homatropine Methylbromide—CHRM5—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00231	0.00239	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00227	0.00235	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00227	0.00235	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—brain—acquired immunodeficiency syndrome	0.00226	0.0682	CbGeAlD
Homatropine Methylbromide—CHRM5—central nervous system—acquired immunodeficiency syndrome	0.00223	0.0672	CbGeAlD
Homatropine Methylbromide—CHRM5—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00222	0.00229	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00222	0.00229	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00219	0.00227	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00217	0.00225	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00217	0.00225	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.0021	0.00217	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00209	0.00217	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00206	0.00213	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00206	0.00213	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00206	0.00213	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00205	0.00212	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00203	0.0021	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00201	0.00207	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00197	0.00204	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00197	0.00204	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00185	0.00192	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00185	0.00191	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00183	0.00189	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—brain—acquired immunodeficiency syndrome	0.00177	0.0533	CbGeAlD
Homatropine Methylbromide—CHRM2—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	0.00177	0.00183	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00173	0.00178	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.0017	0.00176	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—digestive system—acquired immunodeficiency syndrome	0.00167	0.0505	CbGeAlD
Homatropine Methylbromide—CHRM5—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00165	0.00171	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00163	0.00169	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00163	0.00168	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00163	0.00168	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00163	0.00168	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00162	0.00168	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00161	0.00167	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00161	0.00166	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—nervous system—acquired immunodeficiency syndrome	0.00159	0.0479	CbGeAlD
Homatropine Methylbromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.00159	0.00164	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00157	0.00162	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00156	0.00162	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00156	0.00162	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—lung—acquired immunodeficiency syndrome	0.00156	0.0471	CbGeAlD
Homatropine Methylbromide—CHRM3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00156	0.00161	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00156	0.00161	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00155	0.00161	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00154	0.0016	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00154	0.00159	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00154	0.00159	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—central nervous system—acquired immunodeficiency syndrome	0.00153	0.0461	CbGeAlD
Homatropine Methylbromide—CHRM1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00153	0.00158	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00153	0.00158	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00152	0.00158	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00152	0.00158	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00151	0.00156	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00151	0.00156	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.0015	0.00155	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00149	0.00154	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00148	0.00153	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00148	0.00153	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00147	0.00152	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00146	0.00151	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—nervous system—acquired immunodeficiency syndrome	0.00145	0.0436	CbGeAlD
Homatropine Methylbromide—CHRM4—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00143	0.00148	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.00143	0.00147	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00141	0.00146	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00141	0.00146	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00141	0.00146	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00139	0.00144	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—central nervous system—acquired immunodeficiency syndrome	0.00139	0.042	CbGeAlD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00139	0.00144	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00139	0.00144	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00138	0.00143	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00138	0.00143	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00137	0.00142	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00137	0.00142	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00137	0.00142	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00135	0.0014	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.00129	0.00134	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—nervous system—acquired immunodeficiency syndrome	0.00129	0.039	CbGeAlD
Homatropine Methylbromide—CHRM3—central nervous system—acquired immunodeficiency syndrome	0.00125	0.0376	CbGeAlD
Homatropine Methylbromide—CHRM5—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.00124	0.00128	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.00122	0.00126	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.00122	0.00126	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—brain—acquired immunodeficiency syndrome	0.00121	0.0366	CbGeAlD
Homatropine Methylbromide—CHRM1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.00118	0.00122	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.00117	0.00121	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.00117	0.00121	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00116	0.0012	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00116	0.0012	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00115	0.00119	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00115	0.00119	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00114	0.00118	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00113	0.00117	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.00112	0.00116	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.00111	0.00115	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—brain—acquired immunodeficiency syndrome	0.00111	0.0333	CbGeAlD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00106	0.00109	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00105	0.00109	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00105	0.00108	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00104	0.00108	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00104	0.00108	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00104	0.00108	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00104	0.00107	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00103	0.00107	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00103	0.00106	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—brain—acquired immunodeficiency syndrome	0.000989	0.0298	CbGeAlD
Homatropine Methylbromide—CHRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000965	0.000998	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000962	0.000995	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000953	0.000985	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000952	0.000985	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000949	0.000981	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00094	0.000972	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000926	0.000957	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000912	0.000943	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000898	0.000929	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000887	0.000917	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000873	0.000903	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000873	0.000903	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.00087	0.0009	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000861	0.000891	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.00086	0.00089	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000834	0.000863	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.00082	0.000849	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.00082	0.000849	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000818	0.000846	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000818	0.000846	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000816	0.000844	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.00081	0.000838	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.00081	0.000838	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000799	0.000826	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000781	0.000808	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000624	0.000646	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000622	0.000644	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000616	0.000637	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000615	0.000636	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000613	0.000634	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000607	0.000628	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000606	0.000626	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000604	0.000624	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000598	0.000618	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000562	0.000582	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000561	0.00058	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000555	0.000574	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.00055	0.000569	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000548	0.000567	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000543	0.000562	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000482	0.000498	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000479	0.000496	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—ALB—acquired immunodeficiency syndrome	0.000478	0.000494	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000461	0.000477	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000459	0.000475	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000325	0.000336	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000324	0.000335	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000323	0.000334	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000322	0.000333	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000321	0.000332	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000319	0.00033	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000283	0.000293	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000271	0.000281	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000191	0.000198	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.00019	0.000197	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000189	0.000195	CbGpPWpGaD
